Go Pro
NASDAQ:BNBX

Applied Dna Sciences (BNBX) Stock Price, News & Analysis

Applied Dna Sciences logo
$0.15 0.00 (-0.86%)
As of 11:05 AM Eastern

About Applied Dna Sciences Stock (NASDAQ:BNBX)

Advanced

Key Stats

Today's Range
$0.14
$0.18
50-Day Range
$0.08
$0.39
52-Week Range
$0.07
$7.15
Volume
17,754 shs
Average Volume
446,798 shs
Market Capitalization
$929.55 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers. The company supports those markers with laboratory services—using PCR and sequencing techniques—to analyze samples, produce digital chain-of-custody reports and provide verification for customers. Its business model includes product sales, licensing and contract testing or integration work tailored to customer requirements.

Applied DNA’s solutions are used by organizations that need robust provenance and anti-counterfeiting measures, including manufacturers, distributors and entities in regulated industries. The company provides services to customers in the United States and internationally, seeking to address global supply-chain vulnerabilities by combining intellectual property, laboratory capability and field-deployable tagging technologies. Applied DNA Sciences is publicly traded on the NASDAQ.

AI Generated. May Contain Errors.

Receive BNBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied Dna Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BNBX Stock News Headlines

See More Headlines

BNBX Stock Analysis - Frequently Asked Questions

Applied Dna Sciences' stock was trading at $1.51 on January 27, 2026. Since then, BNBX stock has decreased by 88.1% and is now trading at $0.18.

Applied Dna Sciences Inc (NASDAQ:BNBX) released its earnings results on Thursday, August, 13th. The company reported ($0.57) earnings per share for the quarter. The business earned $0.61 million during the quarter. Applied Dna Sciences had a negative trailing twelve-month return on equity of 349.95% and a negative net margin of 1,647.25%.

Shares of BNBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/13/2026
Today
9/03/2026
Fiscal Year End
9/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:BNBX
CIK
744452
Employees
70
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.33)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.16 million
Net Margins
-1,647.25%
Pretax Margin
-1,671.00%
Return on Equity
-349.95%
Return on Assets
-283.96%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.82
Quick Ratio
1.74

Sales & Book Value

Annual Sales
$2.09 million
Price / Sales
0.44
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.50 per share
Price / Book
0.10

Miscellaneous

Outstanding Shares
6,197,000
Free Float
6,755,000
Market Cap
$929.55 thousand
Optionable
N/A
Beta
0.60
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:BNBX) was last updated on 9/3/2026 by MarketBeat.com Staff.
From Our Partners